pfizer–biontech updated mrna fall 2023 vaccine Search Results


updated pfizer-biontech covid-19 mrna fall 2023 vaccine  (BioNTech)
90
BioNTech updated pfizer-biontech covid-19 mrna fall 2023 vaccine
Impact of scenario analyses on the projected incremental cost-effectiveness results with a <t>COVID-19</t> vaccine updated for <t>Fall</t> <t>2023</t>
Updated Pfizer Biontech Covid 19 Mrna Fall 2023 Vaccine, supplied by BioNTech, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/pfizer%E2%80%93biontech+updated+mrna+fall+2023+vaccine/pfizer+biontech+fall+2023+vaccine/med_rxiv__2023__12__04__23299402-23-16-22
Average 90 stars, based on 1 article reviews
updated pfizer-biontech covid-19 mrna fall 2023 vaccine - by Bioz Stars, 2026-09
90/100 stars
  Buy from Supplier
bnt162b2  (BioNTech)
90
BioNTech bnt162b2
Impact of scenario analyses on the projected incremental cost-effectiveness results with a <t>COVID-19</t> vaccine updated for <t>Fall</t> <t>2023</t>
Bnt162b2, supplied by BioNTech, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/pfizer%E2%80%93biontech+updated+mrna+fall+2023+vaccine/bnt162b2/pmc11872700-44-13-15
Average 90 stars, based on 1 article reviews
bnt162b2 - by Bioz Stars, 2026-09
90/100 stars
  Buy from Supplier
covid-19 vaccination  (BioNTech)
90
BioNTech covid-19 vaccination
Impact of scenario analyses on the projected incremental cost-effectiveness results with a <t>COVID-19</t> vaccine updated for <t>Fall</t> <t>2023</t>
Covid 19 Vaccination, supplied by BioNTech, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/pfizer%E2%80%93biontech+updated+mrna+fall+2023+vaccine/covid+19+vaccination/med_rxiv__2025__01__03__25319975-134-11-12
Average 90 stars, based on 1 article reviews
covid-19 vaccination - by Bioz Stars, 2026-09
90/100 stars
  Buy from Supplier
comirnaty  (BioNTech)
90
BioNTech comirnaty
Impact of scenario analyses on the projected incremental cost-effectiveness results with a <t>COVID-19</t> vaccine updated for <t>Fall</t> <t>2023</t>
Comirnaty, supplied by BioNTech, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/pfizer%E2%80%93biontech+updated+mrna+fall+2023+vaccine/comirnaty/med_rxiv__2025__01__03__25319975-21-7-13
Average 90 stars, based on 1 article reviews
comirnaty - by Bioz Stars, 2026-09
90/100 stars
  Buy from Supplier
monovalent mrna pfizer-biontech covid-19 vaccine  (BioNTech)
90
BioNTech monovalent mrna pfizer-biontech covid-19 vaccine
Impact of scenario analyses on the projected incremental cost-effectiveness results with a <t>COVID-19</t> vaccine updated for <t>Fall</t> <t>2023</t>
Monovalent Mrna Pfizer Biontech Covid 19 Vaccine, supplied by BioNTech, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/pfizer%E2%80%93biontech+updated+mrna+fall+2023+vaccine/monovalent+mrna+pfizer+biontech+covid+19+vaccine/pmc10779890-45-4-7
Average 90 stars, based on 1 article reviews
monovalent mrna pfizer-biontech covid-19 vaccine - by Bioz Stars, 2026-09
90/100 stars
  Buy from Supplier
ivt-mrna modified with the more recently proposed uridine analog m1ψ  (BioNTech)
90
BioNTech ivt-mrna modified with the more recently proposed uridine analog m1ψ
Impact of scenario analyses on the projected incremental cost-effectiveness results with a <t>COVID-19</t> vaccine updated for <t>Fall</t> <t>2023</t>
Ivt Mrna Modified With The More Recently Proposed Uridine Analog M1ψ, supplied by BioNTech, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/pfizer%E2%80%93biontech+updated+mrna+fall+2023+vaccine/ivt+mrna+modified+with+the+more+recently+proposed+uridine+analog+m1%CF%88/pm36634491-282-16-20
Average 90 stars, based on 1 article reviews
ivt-mrna modified with the more recently proposed uridine analog m1ψ - by Bioz Stars, 2026-09
90/100 stars
  Buy from Supplier
monovalent pfizer-biontech doses  (BioNTech)
90
BioNTech monovalent pfizer-biontech doses
Impact of scenario analyses on the projected incremental cost-effectiveness results with a <t>COVID-19</t> vaccine updated for <t>Fall</t> <t>2023</t>
Monovalent Pfizer Biontech Doses, supplied by BioNTech, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/pfizer%E2%80%93biontech+updated+mrna+fall+2023+vaccine/pfizer+biontech+monovalent+vaccine/pmc10441825-86-24-24
Average 90 stars, based on 1 article reviews
monovalent pfizer-biontech doses - by Bioz Stars, 2026-09
90/100 stars
  Buy from Supplier
september 2023  (Pfizer Inc)
86
Pfizer Inc september 2023
Impact of scenario analyses on the projected incremental cost-effectiveness results with a <t>COVID-19</t> vaccine updated for <t>Fall</t> <t>2023</t>
September 2023, supplied by Pfizer Inc, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/pfizer%E2%80%93biontech+updated+mrna+fall+2023+vaccine/2023+september/pmc12505990-59-1-16
Average 86 stars, based on 1 article reviews
september 2023 - by Bioz Stars, 2026-09
86/100 stars
  Buy from Supplier
modrna based combination  (Pfizer Inc)
86
Pfizer Inc modrna based combination
Impact of scenario analyses on the projected incremental cost-effectiveness results with a <t>COVID-19</t> vaccine updated for <t>Fall</t> <t>2023</t>
Modrna Based Combination, supplied by Pfizer Inc, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/pfizer%E2%80%93biontech+updated+mrna+fall+2023+vaccine/based+combination+modrna/pmc12390046-41-3-6
Average 86 stars, based on 1 article reviews
modrna based combination - by Bioz Stars, 2026-09
86/100 stars
  Buy from Supplier
bivalent pfizer-biontech dose  (BioNTech)
90
BioNTech bivalent pfizer-biontech dose
Reactions and health impacts reported to v-safe during days 0–7 postvaccination among children aged 6 months–5 years <xref ref-type= * who received a third dose of Pfizer-BioNTech or Moderna COVID-19 vaccine — United States, June 17, 2022–May 7, 2023" width="250" height="auto" />
Bivalent Pfizer Biontech Dose, supplied by BioNTech, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/pfizer%E2%80%93biontech+updated+mrna+fall+2023+vaccine/pfizer+biontech+bivalent+vaccine/pmc10328461-140-25-26
Average 90 stars, based on 1 article reviews
bivalent pfizer-biontech dose - by Bioz Stars, 2026-09
90/100 stars
  Buy from Supplier
pfizer-biontech 2558 pediatric nephrology  (BioNTech)
90
BioNTech pfizer-biontech 2558 pediatric nephrology
Reactions and health impacts reported to v-safe during days 0–7 postvaccination among children aged 6 months–5 years <xref ref-type= * who received a third dose of Pfizer-BioNTech or Moderna COVID-19 vaccine — United States, June 17, 2022–May 7, 2023" width="250" height="auto" />
Pfizer Biontech 2558 Pediatric Nephrology, supplied by BioNTech, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/pfizer%E2%80%93biontech+updated+mrna+fall+2023+vaccine/pfizer+biontech+2558+pediatric+nephrology/pm36260163-214-13-13
Average 90 stars, based on 1 article reviews
pfizer-biontech 2558 pediatric nephrology - by Bioz Stars, 2026-09
90/100 stars
  Buy from Supplier
2023–2024 covid-19 vaccines  (BioNTech)
90
BioNTech 2023–2024 covid-19 vaccines
Reactions and health impacts reported to v-safe during days 0–7 postvaccination among children aged 6 months–5 years <xref ref-type= * who received a third dose of Pfizer-BioNTech or Moderna COVID-19 vaccine — United States, June 17, 2022–May 7, 2023" width="250" height="auto" />
2023–2024 Covid 19 Vaccines, supplied by BioNTech, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/pfizer%E2%80%93biontech+updated+mrna+fall+2023+vaccine/2023+2024+covid+19+vaccines/med_rxiv__2025__01__03__25319975-4-5-8
Average 90 stars, based on 1 article reviews
2023–2024 covid-19 vaccines - by Bioz Stars, 2026-09
90/100 stars
  Buy from Supplier

Image Search Results


Impact of scenario analyses on the projected incremental cost-effectiveness results with a COVID-19 vaccine updated for Fall 2023

Journal: medRxiv

Article Title: The potential economic impact of the updated COVID-19 mRNA fall 2023 vaccines in Japan

doi: 10.1101/2023.12.04.23299402

Figure Lengend Snippet: Impact of scenario analyses on the projected incremental cost-effectiveness results with a COVID-19 vaccine updated for Fall 2023

Article Snippet: Second, the Moderna Fall Campaign was compared to vaccination of individuals aged ≥18years with the updated Pfizer-BioNTech COVID-19 mRNA Fall 2023 vaccine (Pfizer-BioNTech Fall Campaign).

Techniques:

Reactions and health impacts reported to v-safe during days 0–7 postvaccination among children aged 6 months–5 years <xref ref-type= * who received a third dose of Pfizer-BioNTech or Moderna COVID-19 vaccine — United States, June 17, 2022–May 7, 2023" width="100%" height="100%">

Journal: Morbidity and Mortality Weekly Report

Article Title: Safety Monitoring of mRNA COVID-19 Vaccine Third Doses Among Children Aged 6 Months–5 Years — United States, June 17, 2022–May 7, 2023

doi: 10.15585/mmwr.mm7223a2

Figure Lengend Snippet: Reactions and health impacts reported to v-safe during days 0–7 postvaccination among children aged 6 months–5 years * who received a third dose of Pfizer-BioNTech or Moderna COVID-19 vaccine — United States, June 17, 2022–May 7, 2023

Article Snippet: Reports to VAERS were included for children aged 6 months–4 years who received a third monovalent Pfizer-BioNTech dose during June 17, 2022–May 7, 2023, or bivalent Pfizer-BioNTech dose during December 8, 2022–May 7, 2023, and for children aged 6 months–5 years who received a third monovalent Moderna dose during June 17, 2022–May 7, 2023, or bivalent Moderna dose during December 8, 2022–May 7, 2023.

Techniques: Injection

Reactions most commonly reported to v-safe during days 0–7 postvaccination for children ages 6 months–5 years (N = 2,969) <xref ref-type= * who received a third dose of Pfizer-BioNTech or Moderna COVID-19 vaccine, by severity — United States, June 17, 2022–May 7, 2023" width="100%" height="100%">

Journal: Morbidity and Mortality Weekly Report

Article Title: Safety Monitoring of mRNA COVID-19 Vaccine Third Doses Among Children Aged 6 Months–5 Years — United States, June 17, 2022–May 7, 2023

doi: 10.15585/mmwr.mm7223a2

Figure Lengend Snippet: Reactions most commonly reported to v-safe during days 0–7 postvaccination for children ages 6 months–5 years (N = 2,969) * who received a third dose of Pfizer-BioNTech or Moderna COVID-19 vaccine, by severity — United States, June 17, 2022–May 7, 2023

Article Snippet: Reports to VAERS were included for children aged 6 months–4 years who received a third monovalent Pfizer-BioNTech dose during June 17, 2022–May 7, 2023, or bivalent Pfizer-BioNTech dose during December 8, 2022–May 7, 2023, and for children aged 6 months–5 years who received a third monovalent Moderna dose during June 17, 2022–May 7, 2023, or bivalent Moderna dose during December 8, 2022–May 7, 2023.

Techniques: Injection

Reports of nonserious and serious events to the Vaccine Adverse Event Reporting System for children aged 6 months–5 years <xref ref-type= * after receipt of dose 3 Pfizer-BioNTech or Moderna COVID-19 vaccine † — United States, June 17, 2022–May 7, 2023" width="100%" height="100%">

Journal: Morbidity and Mortality Weekly Report

Article Title: Safety Monitoring of mRNA COVID-19 Vaccine Third Doses Among Children Aged 6 Months–5 Years — United States, June 17, 2022–May 7, 2023

doi: 10.15585/mmwr.mm7223a2

Figure Lengend Snippet: Reports of nonserious and serious events to the Vaccine Adverse Event Reporting System for children aged 6 months–5 years * after receipt of dose 3 Pfizer-BioNTech or Moderna COVID-19 vaccine † — United States, June 17, 2022–May 7, 2023

Article Snippet: Reports to VAERS were included for children aged 6 months–4 years who received a third monovalent Pfizer-BioNTech dose during June 17, 2022–May 7, 2023, or bivalent Pfizer-BioNTech dose during December 8, 2022–May 7, 2023, and for children aged 6 months–5 years who received a third monovalent Moderna dose during June 17, 2022–May 7, 2023, or bivalent Moderna dose during December 8, 2022–May 7, 2023.

Techniques: Infection, Injection